Structure Therapeutics Inc.
GPCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $397,855 | $992,728 | $1,553,623 |
| - Cash | $102,912 | $147,027 | $152,123 | $169,510 |
| + Debt | $4,288 | $7,676 | $7,587 | $3,862 |
| Enterprise Value | – | $258,505 | $848,192 | $1,387,975 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$65,313 | -$70,160 | -$56,037 | -$46,788 |
| % Margin | – | – | – | – |
| Net Income | -$65,712 | -$61,661 | -$46,833 | -$36,479 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.11 | -1.08 | -0.81 | -0.63 |
| % Growth | -2.8% | -33.3% | -28.6% | – |
| Operating Cash Flow | -$50,996 | -$54,558 | -$52,229 | -$36,467 |
| Capital Expenditures | -$1,572 | -$232 | -$314 | -$16 |
| Free Cash Flow | -$52,568 | -$54,790 | -$52,543 | -$36,483 |